A look at what’s ahead in health care for older Americans
March 1, 2019
As administrator of the Centers for Medicare & Medicaid Services (CMS), Seema Verma plays one of the most important roles in deciding how more than 130 million Americans get health care. She directs the planning, coordination and implementation of Medicare, Medicaid and the health care exchanges of the Affordable Care Act (ACA), programs that make up almost a third of the federal budget and provide care for some of America’s oldest, sickest and poorest people.
In an interview with AARP, Verma talked about her vision for Medicare and Medicaid, prescription drug prices and her views on the Affordable Care Act.
What is Medicare’s future?
What we want to do is make sure that the program is sustainable over the long term. That doesn’t mean that we’re trying to ration health care. We want to modernize it and make sure that patients have access to the latest technology and innovation.
Will the eligibility age for Medicare be raised in the next decade?
I think that’s going to be an issue for Congress. What I would say is that the program was designed 50 years ago. Now people are living longer. They’re also dealing with more chronic health conditions. I think that the program is going to have to evolve.
Would that evolution include a raised eligibility age?
I don’t have a strong, fast, definitive answer on that, but I think that we’ve got to figure out how to make this program work in a more sustainable way.
Will both original Medicare and Medicare Advantage plans — in which beneficiaries get all care through a private health network — be here for the long term?
For me, it’s very important that patients always have choices. That being said, I think the way the Medicare Advantage [MA] program is evolving is becoming more and more attractive to patients. The recent move that we made around allowing more supplemental benefits and giving plans the ability to target benefits, I think is really critical. Maybe they need a ride to the doctor’s office or some nutritional support or a ramp to help prevent falls. The ability for MA plans to have that flexibility and offer more benefits, I think, [means] that there is going to be an attraction for Medicare beneficiaries to pick that type of plan.
Shouldn’t those on original Medicare get those extra services?
I think the idea is giving choices to people. There are going to be some differences between the two. There are going to be trade-offs. You might pick a plan that has more benefits. You might pick a plan that has a wider network.
What can CMS do to make it easier for Medicare beneficiaries to appeal a coverage determination, especially when it comes to Medicare Advantage plans?
If they disagree with the plan’s decision, they should always have the ability to appeal. We also make sure that they have expedited appeals. Some can be processed in 24 hours. We want to do everything that we can to protect patients and make sure that they have access. That’s something that we’re going to continue to work on to make sure that seniors understand their rights and responsibilities.
AARP members are concerned about fraud and abuse in Medicare. What can your agency do to combat that?
I don’t think that we are leveraging all the possibilities. Some of the things that I think we want to be able to do are some of the moves that we’re making around empowering patients and giving them more information about cost and quality in their health care record. I think that’s about the partnership that we have with beneficiaries. They can help us on fraud and abuse. They understand what’s being charged, and we can continue to work with them. You’re going to see us put more out on that to try and strengthen that process.
How can the government help lower prescription drug prices?
I don’t think there is a silver bullet. What we know does work are competition and negotiation. When there is competition, you do see the cost of drugs go down. That’s what we’re doing in Part D — giving them more tools so that they can drive down costs.
AARP has fought to have Medicare bargain directly with pharmaceutical companies. Are you for that?
We [already] hire negotiators on our behalf. Those are the Part D plans. And they’ve actually been doing a pretty great job. If you look at the Part D premiums, they’ve been relatively flat. They’ve actually gone down in the last couple of years. If the government starts negotiating directly, there’s not going to be a lot of choices [because there will be one master list of drugs that are covered, called a formulary].
The Veterans Health Administration negotiates directly for its prescription drugs. Why can’t Medicare?
They have one formulary. They’re not offering all the different medications. There aren’t choices. When it’s the government doing [the negotiating], there’s no competition and you have the government making decisions — not individuals, not patients.
What can you tell us about the status of the Affordable Care Act?
This year what we saw for the very first time was rate stability. And in some cases, we saw that the rates actually went down by 26 percent.
We hear from AARP members that they want to live out their lives at home, not in a nursing home, if they can help it. But it’s still harder to get home- and community-based services than it is to get institutional care. Can that be changed?
I think that’s a goal that we all have. We’re all going to be more comfortable in our own homes. Some of the moves that we made in Medicare Advantage with supplemental benefits are aimed at creating independence, quality of care and quality of life. We’re going to continue to work with states to make sure that home- and community-based care works well and that it’s a fruitful option for beneficiaries. Ultimately, the states have to figure out what’s going to work best for their communities.
The government is spending less to inform people of the availability of ACA health insurance. Do you support that?
You can have all the advertising in the world, which is what we had with the previous administration, but enrollment actually went down because when plans are so expensive, people aren’t going to want to purchase them. What we’ve focused on is making sure that people have choices of health plans and lower costs. I think we’re making progress. It’s still not fixed. Some of the larger fixes are going to need to be made by Congress.
コメント